Breaking Ground in Prostate Cancer: BriaCell Announces Lead Prostate Cancer Candidate Bria-Pros+, Initiates GMP Manufacturing

Bria-Pros+ is based on BriaCell's next generation personalized immunotherapy platform • Bria-Pros+ is capable of activating multiple types of immune cells, including helper T cells, cytotoxic (killer) T cells and natural killer cells PHILADELPHIA and VANCOUVER, British Columbia, Feb. 06, 2024…#briacell #briapros #philadelphia #britishcolumbia #gmp #sitc #williamvwilliams #hla #classicalnk #nkt
Source: Reuters: Health - Category: Consumer Health News Source Type: news